Prognostic factors and clinical significance of preoperative systemic therapy in patients with borderline resectable hepatocellular carcinoma: A <scp>JSHBPS</scp> project study 2023, Part 2
Multicenter data confirm the clinical relevance of the oncological resectability category and the potential advantage of preceding systemic therapy in a specific group of BR-HCC.
Authors
- Akihiko Ichida
- Masaru Matsumura (ORCID: https://orcid.org/0000-0001-7898-7595)
- Takamichi Ishii (ORCID: https://orcid.org/0000-0002-7461-9653)
- Masayuki Ohtsuka (ORCID: https://orcid.org/0000-0002-5091-1078)
- Etsuro Hatano (ORCID: https://orcid.org/0000-0003-3407-1918)
- Kiyoshi Hasegawa (ORCID: https://orcid.org/0000-0001-8734-740X)
- Shohei Komatsu (ORCID: https://orcid.org/0000-0001-9059-2473)
- Takumi Fukumoto
- Masafumi Nakamura (ORCID: https://orcid.org/0000-0003-2520-8628)
Institutions
- Kyoto University (JP)
- Okinaka Memorial Adult Disease Research Institute (JP)
- Toranomon Hospital (JP)
- Okinaka Memorial Institute for Medical Research
- Kobe University (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Journal of Hepato-Biliary-Pancreatic Sciences
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1002/jhbp.12138
- Citations
- 5
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 6.61